Acute phase proteins and transformed cells.
Acute phase proteins (APP) are plasma proteins whose concentration and glycosylation alters in response to tissue injury, inflammation, or tumor growth. Significant interspecies and sex differences in APP response exist. APP are produced mainly by hepatocytes, and their synthesis and glycosylation are controlled by a network consisting of cytokines, their soluble receptors, and glucocorticoids. The major cytokines involved in these processes belong to a group of interleukin-6-type cytokines that act through the hematopoietin receptor complex on hepatocytes and JAK-STAT signal transduction pathway. Transformed cells (hepatoma) display significant differences in synthesis of APP, cytokine responsiveness, expression of cytokine-receptor subunits and signal-transduction machinery. The most striking variability relates to the glycosylation alterations induced by cytokines. However, transformed cells (hepatoma) form a basic model for studying and understanding mechanisms controlling the synthesis and glycosylation of APP. Furthermore, APP may be secreted by transformed (tumor) cells of various origins and may display a growth factor-like function in certain cancer types.
Mackiewicz
A
A
Department of Cancer Immunology, University School of Medical Sciences, GreatPoland Cancer Center, Poznań, Poland.
D000209:Acute-Phase Proteins / Q000502:physiology*; D000818:Animals; D002468:Cell Physiological Phenomena; D002477:Cells / Q000737:chemistry; D006801:Humans; D014170:Transformation, Genetic
D000209:Acute-Phase Proteins